Company Scala Clinical Research Srl with Fiscal Code 29956869
recorded a turnover of 2022 of
5.919,
with a net profit of
2.700
and having an average number of employees of
- .
The company operates in the field of Cercetare-dezvoltare in biotehnologie having the NACE code 7211.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Scala Clinical Research Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
314.117
142.419
225.487
210.624
187.687
96.912
41.751
5.971
-
-
Total Income - EUR
314.117
142.802
226.274
212.200
189.344
106.328
41.960
12.015
-
-
Total Expenses - EUR
313.452
100.779
164.758
135.324
167.765
92.691
17.936
8.967
-
-
Gross Profit/Loss - EUR
666
42.023
61.517
76.876
21.579
13.637
24.024
3.048
-
-
Net Profit/Loss - EUR
304
35.292
59.062
74.768
19.701
12.709
22.999
2.724
-
-
Employees
11
6
5
5
5
4
0
0
-
-
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -85.7%, from 41.751 euro in the year 2021, to 5.971 euro in 2022.
The Net Profit decreased by -20.347 euro, from 22.999 euro in 2021, to 2.724 in the last year.
Check the financial reports for the company - Scala Clinical Research Srl
Financial Rating - SCALA CLINICAL RESEARCH SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Scala Clinical Research Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Scala Clinical Research Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Scala Clinical Research Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Scala Clinical Research Srl - CUI 29956869
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
2.746
578
5.549
4.283
2.535
10.451
7.294
4.383
-
-
Current Assets
37.534
68.791
106.443
149.676
132.564
107.960
85.095
81.457
-
-
Inventories
0
0
0
0
0
0
0
0
-
-
Receivables
27.803
58.453
51.369
93.561
97.409
74.397
59.957
58.283
-
-
Cash
9.731
10.338
55.075
56.115
35.155
33.563
25.138
23.174
-
-
Shareholders Funds
1.012
35.559
59.324
130.869
115.040
95.765
76.531
59.773
-
-
Social Capital
225
223
219
215
211
207
202
203
-
-
Debts
39.325
34.044
52.684
23.097
21.792
22.681
15.941
26.221
-
-
Income in Advance
0
0
0
0
0
0
0
0
-
-
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7211 - 7211"
CAEN Financial Year
7211
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
81.457 euro in 2022 which includes Inventories of
0 euro, Receivables of
58.283 euro and cash availability of
23.174 euro.
The company's Equity was valued at
59.773 euro, while total Liabilities amounted to
26.221 euro.
Equity decreased by -16.995 euro, from 76.531 euro in 2021, to 59.773 in 2022.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Scala Clinical Research Srl